Ampudia-Blasco, F. J., Romera, I., Ariño, B., & Gomis, R. (2017). Following the results of the EMPA-REG OUTCOME trial with Empagliflozin, is it possible to speak of a class effect?
Citación estilo ChicagoAmpudia-Blasco, Francisco Javier, Irene Romera, Bernat Ariño, y Ramon Gomis. Following the Results of the EMPA-REG OUTCOME Trial With Empagliflozin, Is It Possible to Speak of a Class Effect? 2017.
Cita MLAAmpudia-Blasco, Francisco Javier, Irene Romera, Bernat Ariño, y Ramon Gomis. Following the Results of the EMPA-REG OUTCOME Trial With Empagliflozin, Is It Possible to Speak of a Class Effect? 2017.
Precaución: Estas citas no son 100% exactas.